化学合成。
医药; 有机合成
合成路线 1(1. 合成:2483-46-7)
产率:100%
合成条件:With sodium hydroxide In 1,4-dioxane; water at 20℃;
实验步骤:向赖氨酸盐酸盐在50ml 1,4-二恶烷/ H 2 O(1:1)中的溶液中加入1M NaOH直至pH达到10-11。 然后通过加料漏斗加入在二恶烷中的Boc酐(6.0g在20ml二恶烷中)。 将得到的溶液在室温下搅拌过夜。 将混合物真空浓缩,用4M KHSO 4酸化至pH = 1-2。 用乙酸乙酯萃取两次并真空干燥。 获得无色液体并且产率为100%
参考文献:
- [1] Patent: US2014/127138, 2014, A1. Location in patent: Paragraph 0321; 0322 [2] Patent: US2016/376618, 2016, A1. Location in patent: Paragraph 0206-0212 [3] Journal of Medicinal Chemistry, 2014, vol. 57, # 4, p. 1428 - 1436 [4] Patent: WO2014/97178, 2014, A1. Location in patent: Page/Page column 49 [5] New Journal of Chemistry, 2018, vol. 42, # 5, p. 3192 - 3195 [6] Russian Journal of Applied Chemistry, 2005, vol. 78, # 6, p. 1003 - 1007 [7] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6891 - 6899 [8] Patent: WO2013/11526, 2013, A1. Location in patent: Page/Page column 15-16
合成路线 2(2. 合成:2483-46-7)
产率:92%
合成条件:With sodium hydroxide In 1,4-dioxane; water at 20℃; for 12 h;
实验步骤:向L-赖氨酸一水合物(5.09g,31.0mmol)的水/二恶烷(1:1,100mL)溶液中加入二碳酸二叔丁酯(16.9g,78.0mmol)和1N NaOH水溶液(35mL))。 将反应混合物在室温下搅拌12小时,然后真空浓缩直至剩余约50mL。 通过小心加入KHSO 4水溶液(150g / L)将pH调节至1-2。 将悬浮液用乙酸乙酯萃取三次。 将合并的有机层用MgSO 4干燥,减压除去溶剂,得到产物(9.89g,28.5mmol,92%),为油状物。 1H NMR(DMSO-d6,200.1MHz):δ= 12.40(s,1H,OH),6.98(d,J = 7.9Hz,1H),6.76(t,J = 5.4Hz,1H),3.75-3.86( m,1H),2.50-2.83(m,2H),1.37(s,18H),1.14-1.68(m,6H)ppm; 13C NMR(DMSO-d6,50.3MHz):δ= 173,155.1,77.4,76.8,52.9,29.9,28.6,27.7,22.4ppm(一个信号,可能约40ppm,被溶剂信号隐藏)。
参考文献:
- [1] Organic and biomolecular chemistry, 2003, vol. 1, # 14, p. 2612 - 2620 [2] Chemistry - A European Journal, 2004, vol. 10, # 23, p. 5901 - 5910 [3] Journal of Materials Chemistry, 2012, vol. 22, # 19, p. 10035 - 10041 [4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 6, p. 1241 - 1250 [5] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 20, p. 4606 - 4609 [6] Patent: WO2012/106588, 2012, A2. Location in patent: Page/Page column 17-18 [7] Journal of Medicinal Chemistry, 2017, vol. 60, # 9, p. 3684 - 3702 [8] Patent: WO2018/187867, 2018, A1. Location in patent: Page/Page column 24 [9] Helvetica Chimica Acta, 2000, vol. 83, # 2, p. 322 - 327 [10] Organic and Biomolecular Chemistry, 2013, vol. 11, # 21, p. 3461 - 3468 [11] Journal of the American Chemical Society, 2000, vol. 122, # 33, p. 7927 - 7935 [12] Tetrahedron, 2003, vol. 59, # 31, p. 5837 - 5848 [13] Angewandte Chemie - International Edition, 2014, vol. 53, # 4, p. 1113 - 1117 [14] Angew. Chem., 2013, vol. 126, # 04, p. 1131 - 1135,5 [15] European Journal of Medicinal Chemistry, 2018, vol. 143, p. 1489 - 1509 [16] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 925 - 945 [17] Patent: CN105566149, 2016, A. Location in patent: Paragraph 0043; 0044; 0045 [18] Chemical Communications, 2015, vol. 51, # 31, p. 6832 - 6835 [19] Journal of Biological Chemistry, 2013, vol. 288, # 34, p. 24717 - 24730 [20] Molecular Crystals and Liquid Crystals (1969-1991), 1989, vol. 170, p. 195 - 214 [21] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 23, p. 9984 - 9990 [22] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2012, vol. 67, # 7, p. 731 - 746 [23] Macromolecules, 2015, vol. 48, # 6, p. 1688 - 1702 [24] Journal of Medicinal Chemistry, 2016, vol. 59, # 23, p. 10520 - 10529 [25] Patent: WO2017/14332, 2017, A1. Location in patent: Paragraph 74; 75 [26] Patent: CN106995384, 2017, A. Location in patent: Paragraph 0065; 0066 [27] Patent: CN107382893, 2017, A. Location in patent: Paragraph 0035-0036
合成路线 3(3. 合成:2483-46-7)
产率:93%
合成条件:With triethylamine In 1,4-dioxane; water for 18 h; Cooling with ice
实验步骤:将Nα-(叔丁氧基羰基)-L-赖氨酸(1)(985mg,4mmol)溶于无水1,4-二恶烷(3mL)和水(3mL)中。加入三乙胺(615μL,4.4mmol)后,在冰冷却下向该溶液中滴加二碳酸二叔丁酯(960mg,4.4mmol),然后将混合物搅拌18小时。通过TLC(乙酸乙酯:正己烷= 5:1)确认反应完成,并将反应溶液倒入0.5N盐酸水溶液(80mL)中。用乙酸乙酯(3×40mL)萃取混合物,用饱和盐水(80mL)洗涤有机层,用无水硫酸镁干燥。减压蒸发后,通过快速柱色谱法(乙酸乙酯:正己烷= 1:1至2:1)纯化所得物质,得到中间体2(1.29g,93%),为白色固体。 1H-NMR(300MHz,CDCl3)δ:5.21(br s,1H),4.62(br s,1H),4.28(br s,1H),3.14(d,2H,J = 6.0Hz), 1.88(br s,1H),1.76(br s,1H),1.45-1.23(m,22H),0.92-0.88(m,1H)。
参考文献:
- [1] Patent: US2015/80551, 2015, A1. Location in patent: Paragraph 0043; 0044